Tissue-specific regulatory regions of the PTH gene localized by novel chromosome 11 rearrangement breakpoints in a parathyroid adenoma

Journal of Bone and Mineral Research

Volumn 25, Issue 12, 2010, Pages 2606-2612

  Mallya, Sanjay M ^a,b   Wu, H Irene ^c   Saria, Elizabeth A ^b   Corrado, Kristin R ^b   Arnold, Andrew ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c PALO ALTO MEDICAL FOUNDATION   (United States)

Author keywords

Cyclin D1; Hyperparathyroidism; Parathyroid Hormone; Parathyroid Neoplasia; PTH

Indexed keywords

CYCLIN D1; MESSENGER RNA; PARATHYROID HORMONE;

AGED; ARTICLE; CASE REPORT; CHROMOSOME 11; CHROMOSOME BREAKAGE; CHROMOSOME REARRANGEMENT; GENE LOCATION; GENE LOCUS; GENE OVEREXPRESSION; HUMAN; MALE; MOLECULAR CLONING; PARATHYROID ADENOMA; REGULATORY SEQUENCE; TISSUE SPECIFICITY;

EID: 78649615817     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.187     Document Type: Article

References (42)

1. Arnold A, Staunton CE, Kim HG, et al. Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. N Engl J Med. 1988; 318: 658-662.
2. Arnold A, Kim HG, Gaz RD, et al. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J Clin Invest. 1989; 83: 2034-2040.
3. Motokura T, Bloom T, Kim HG, et al. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature. 1991; 350: 512-515.
4. Rosenberg CL, Kim HG, Shows TB, et al. Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. Oncogene. 1991; 6: 449-453.
5. Rosenberg CL, Wong E, Petty EM, et al. PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci. USA. 1991; 88: 9638-9642.
6. Williams ME, Swerdlow SH, Rosenberg CL, et al. Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma. Leukemia. 1993; 7: 241-245.
7. Janssen JW, Vaandrager JW, Heuser T, et al. Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32). Blood. 2000; 95: 2691-2698.
8. Vaandrager JW, Kluin P, Schuuring E., The t(11;14) (q13;q32) in multiple myeloma cell line KMS12 has its 11q13 breakpoint 330kb centromeric from the cyclin D1 gene. Blood. 1997; 89: 349-350.
9. Jhang JS, Narayan G, Murty VV, et al. Renal oncocytomas with 11q13 rearrangements: cytogenetic, molecular, and immunohistochemical analysis of cyclin D1. Cancer Genet Cytogenet. 2004; 149: 114-119.
10. Sinke RJ, Dijkhuizen T, Janssen B, et al. Fine mapping of the human renal oncocytoma-associated translocation (5;11)(q35;q13) breakpoint. Cancer Genet Cytogenet. 1997; 96: 95-101.
11. Zanssen S, Gunawan B, Fuzesi L, et al. Renal oncocytomas with rearrangements involving 11q13 contain breakpoints near CCND1. Cancer Genet Cytogenet. 2004; 149: 120-124.
12. Hsi ED, Zukerberg LR, Yang WI, et al. Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study. J Clin Endocrinol Metab. 1996; 81: 1736-1739.
13. Ikeda S, Ishizaki Y, Shimizu Y, et al. Immunohistochemistry of cyclin D1 and beta-catenin, and mutational analysis of exon 3 of beta-catenin gene in parathyroid adenomas. Int J Oncol. 2002; 20: 463-466.
14. Tominaga Y, Tsuzuki T, Uchida K, et al. Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma. Kidney Int. 1999; 55: 1375-1383.
15. Vasef MA, Brynes RK, Sturm M, et al. Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study. Mod Pathol. 1999; 12: 412-416.
16. Imanishi Y, Hosokawa Y, Yoshimoto K, et al. Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. J Clin Invest. 2001; 107: 1093-1102.
17. Mallya SM, Gallagher JJ, Wild YK, et al. Abnormal parathyroid cell proliferation precedes biochemical abnormalities in a mouse model of primary hyperparathyroidism. Mol Endocrinol. 2005; 19: 2603-2609.
18. Danks JA, Ho PM, Notini AJ, et al. Identification of a parathyroid hormone in the fish Fugu rubripes. J Bone Miner Res. 2003; 18: 1326-1331.
19. He B, Tong TK, Hiou-Tim FF, et al. The murine gene encoding parathyroid hormone: genomic organization, nucleotide sequence and transcriptional regulation. J Mol Endocrinol. 2002; 29: 193-203.
20. Hendy GN, Kronenberg HM, Potts JT, Jr., et al. Nucleotide sequence of cloned cDNAs encoding human preproparathyroid hormone. Proc Natl Acad Sci U S A. 1981; 78: 7365-7369.
21. Kronenberg HM, McDevitt BE, Majzoub JA, et al. Cloning and nucleotide sequence of DNA coding for bovine preproparathyroid hormone. Proc Natl Acad Sci U S A. 1979; 76: 4981-4985.
22. Vasicek TJ, McDevitt BE, Freeman MW, et al. Nucleotide sequence of the human parathyroid hormone gene. Proc Natl Acad Sci U S A. 1983; 80: 2127-2131.
23. Weaver CA, Gordon DF, Kissil MS, et al. Isolation and complete nucleotide sequence of the gene for bovine parathyroid hormone. Gene. 1984; 28: 319-329.
24. Demay MB, Kiernan MS, DeLuca HF, et al. Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A. 1992; 89: 8097-8101.
25. Izumi T, Henner WD, Mitra S., Negative regulation of the major human AP-endonuclease, a multifunctional protein. Biochemistry. 1996; 35: 14679-14683.
26. Okazaki T, Chung U, Nishishita T, et al. A redox factor protein, ref1, is involved in negative gene regulation by extracellular calcium. J Biol Chem. 1994; 269: 27855-27862.
27. Okazaki T, Zajac JD, Igarashi T, et al. Negative regulatory elements in the human parathyroid hormone gene. J Biol Chem. 1991; 266: 21903-21910.
28. Rupp E, Mayer H, Wingender E., The promoter of the human parathyroid hormone gene contains a functional cyclic AMP-response element. Nucleic Acids Res. 1990; 18: 5677-5683.
29. Darwish HM, DeLuca HF., Identification of a transcription factor that binds to the promoter region of the human parathyroid hormone gene. Arch Biochem Biophys. 1999; 365: 123-130.
30. Alimov AP, Langub MC, Malluche HH, et al. Sp3/Sp1 in the parathyroid gland: identification of an Sp1 deoxyribonucleic acid element in the parathyroid hormone promoter. Endocrinology. 2003; 144: 3138-3147.
31. Alimov AP, Langub MC, Malluche HH, et al. Contrasting mammalian parathyroid hormone (PTH) promoters: nuclear factor-Y binds to a deoxyribonucleic acid element unique to the human PTH promoter and acts as a transcriptional enhancer. Endocrinology. 2004; 145: 2713-2720.
32. Alimov AP, Park-Sarge OK, Sarge KD, et al. Transactivation of the parathyroid hormone promoter by specificity proteins and the nuclear factor Y complex. Endocrinology. 2005; 146: 3409-3416.
33. Bartkova J, Lukas J, Muller H, et al. Cyclin D1 protein expression and function in human breast cancer. Int J Cancer. 1994; 57: 353-361.
34. Parsons JK, Saria EA, Nakayama M, et al. Comprehensive mutational analysis and mRNA isoform quantification of TP63 in normal and neoplastic human prostate cells. Prostate. 2009; 69: 559-569.
35. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature. 2001; 409: 860-921.
36. Kent WJ., BLAT-the BLAST-like alignment tool. Genome Res. 2002; 12: 656-664.
37. Karolchik D, Baertsch R, Diekhans M, et al. The UCSC Genome Browser Database. Nucleic Acids Res. 2003; 31: 51-54.
38. Couronne O, Poliakov A, Bray N, et al. Strategies and tools for whole-genome alignments. Genome Res. 2003; 13: 73-80.
39. Marinescu V, Kohane I, Riva A., MAPPER: a search engine for the computational identification of putative transcription factor binding sites in multiple genomes. BMC Bioinformatics. 2005; 6: 79.
40. Yi Y, Nowak NJ, Pacchia AL, et al. Chromosome 11 genomic changes in parathyroid adenoma and hyperplasia: array CGH, FISH, and tissue microarrays. Genes Chromosomes Cancer. 2008; 47: 639-48.
41. VanHouten JN, Yu N, Rimm D, et al. Hypercalcemia of malignancy due to ectopic transactivation of the parathyroid hormone gene. J Clin Endocrinol Metab. 2006; 91: 580-583.
42. Mizobuchi M, Ritter CS, Krits I, et al. Calcium-sensing receptor expression is regulated by glial cells missing-2 in human parathyroid cells. J Bone Miner Res. 2009; 24: 1173-1179.